Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Quality Control01:05

Quality Control

4.1K
Quality control is one of the three cyclical quality assurance activities that help keep a system under statistical control. Typical quality control activities include creating quality control charts, conducting proficiency testing, and documenting and archiving results.
Quality control helps track data, visualize trends, and identify variations, making it easier to detect deviations that may affect the accuracy of an analysis. One way to do this is by generating a quality control chart, which...
4.1K
Quality Assurance01:19

Quality Assurance

3.8K
Quality assurance is the overarching term used to describe the activities employed to ensure the proper performance of a system. These activities can be classified into three categories: quality control, quality assessment, and internal corrective measures. Typically, these activities work cyclically: quality control is performed before and during the analysis, while quality assessment occurs during and after the investigation. Internal corrective measures are implemented based on the findings...
3.8K
Introduction to Statistical Process Control01:15

Introduction to Statistical Process Control

739
Statistical Process Control (SPC) is a method used to monitor and control quality within processes, particularly in manufacturing and service delivery, by employing statistical methods. SPC aims to distinguish between natural (common cause) variation and variation due to specific changes or events (special cause), allowing for timely improvements and sustained quality. The control chart, a pivotal tool in SPC, visually displays data over time alongside a central line of upper and lower control...
739
In Vitro Drug Release Testing: Overview, Development and Validation01:10

In Vitro Drug Release Testing: Overview, Development and Validation

476
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
476

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

SARS-CoV-2 Omicron infection reveals imprinted antibody responses in the absence of vaccination.

iScience·2026
Same author

Dynamics of Mpox epidemics by the interplay of COVID-19 pandemic in Africa.

BMC medicine·2026
Same author

HIV-1 variants in population-based national surveys in sub-Saharan Africa, 2015-2022.

AIDS (London, England)·2026
Same author

Place susceptibility index mapping at local government scale from population-based survey for Sub-Saharan Africa.

PloS one·2026
Same author

Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults.

Nature communications·2026
Same author

Knowledge, perceptions and acceptance of COVID-19 Vaccine in Plateau States, Nigeria: A Qualitative Study.

medRxiv : the preprint server for health sciences·2025
Same journal

IAS 2025: Why Can't I Breastfeed My Baby When Evidence and Lived Experience Say I Can? A Call for Policy Equity for Mothers Living with HIV.

Current HIV/AIDS reports·2026
Same journal

Cytomegalovirus and HIV Co-Infections During Pregnancy and Early Childhood.

Current HIV/AIDS reports·2026
Same journal

HIV Reservoirs in Brain parenchyma and Cerebrospinal Fluid During Suppressive ART: Same-Same or Very Different?

Current HIV/AIDS reports·2026
Same journal

HIV-1 Tat-driven Glutamate Dysregulation: Implications for Cognitive Impairment in HAND.

Current HIV/AIDS reports·2026
Same journal

Central Nervous System HIV Persistence and Clinical Consequences During Suppressive ART.

Current HIV/AIDS reports·2026
Same journal

Expanding PrEP Access Through Decentralized Delivery Models.

Current HIV/AIDS reports·2026
See all related articles

Related Experiment Video

Updated: Mar 16, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.6K

Laboratory Innovation Towards Quality Program Sustainability.

Alash'le Abimiku1, Ralph Timperi2, William Blattner3,4

  • 1Institute of Human Virology, University of Maryland School of Medicine, 725 W. Lombard Street, Baltimore, MD, 21201, USA. aabimiku@som.umaryland.edu.

Current HIV/AIDS Reports
|August 4, 2016
PubMed
Summary
This summary is machine-generated.

Laboratory innovations enhance HIV program sustainability in low and middle-income countries (LMICs) by improving diagnostics and access to care. Effective implementation within national plans is key to ending the AIDS epidemic.

Keywords:
DiagnosisHIVInnovationLaboratoryPoint-of-careQuality

More Related Videos

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control
05:47

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control

Published on: August 29, 2025

530
The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.6K

Related Experiment Videos

Last Updated: Mar 16, 2026

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
09:30

Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies

Published on: March 17, 2023

4.6K
Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control
05:47

Simulation of a Scaled Assembly Process with Collaboration of a Robotic Arm and Monitoring through a Vision System for Quality Control

Published on: August 29, 2025

530
The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective
04:40

The Cultivation, Growth, and Viability of Lactic Acid Bacteria: A Quality Control Perspective

Published on: June 16, 2022

9.6K

Area of Science:

  • Public Health
  • Laboratory Medicine
  • Infectious Disease Control

Background:

  • Laboratory innovation is crucial for the sustainability of HIV programs in low and middle-income countries (LMICs).
  • Advancements in diagnostics, quality management, and capacity building have significantly impacted HIV care.
  • Effective integration into national strategies is essential for laboratory innovations to achieve their full potential.

Purpose of the Study:

  • To highlight the impact of laboratory innovation on HIV program sustainability in LMICs.
  • To emphasize the role of technological advancements in improving HIV testing and treatment access.
  • To underscore the importance of strategic implementation for achieving global HIV targets.

Main Methods:

  • Review of innovations in diagnostic technologies, quality management systems, and laboratory infrastructure.
  • Analysis of the impact of dried blood spots (DBS) on sample shipment and testing capabilities.
  • Assessment of how laboratory advancements contribute to reaching UNAIDS 90-90-90 targets.

Main Results:

  • Laboratory innovations have reduced costs, improved point-of-care testing, and increased access to HIV services.
  • Dried blood spots facilitate diverse HIV-related analyses, including molecular diagnosis and drug resistance surveillance.
  • These advancements are critical for progressing towards ending the AIDS epidemic.

Conclusions:

  • Laboratory innovation is a key driver for sustainable HIV programs in LMICs.
  • Strategic implementation within national health frameworks maximizes the benefits of laboratory advancements.
  • Continued innovation and integration are vital for achieving global HIV/AIDS control goals.